New nanoparticle-based genetic delivery system targets lungs to treat cancer, cystic fibrosis
Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for patients with conditions like lung cancer and cystic fibrosis.
Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for patients with conditions like lung cancer and cystic fibrosis.
